This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

Automated tool can link brain scans to cognitive deficits in people with neurofibromatosis type 1

Automated tool can link brain scans to cognitive deficits in people with neurofibromatosis 1
FLAIR image of an neurofibromatosis 1 patient’s brain. Bright white spots are representative of UBOs. Credit: VUIIS, Laurie Cutting and Emily Harriott

Researchers in the labs of Laurie Cutting, Patricia and Rodes Hart Professor and professor of special education at the Peabody College of education and human development, and Bennett Landman, professor and chair of the Department of Electrical and Computer Engineering at the School of Engineering, published a study in January in Magnetic Resonance Imaging exploring a new tool for imaging the brains of neurofibromatosis type 1 patients and its significance in assessing their symptoms.

Neurofibromatosis 1 is a disorder caused by mutations in a gene that regulates the production of a tumor suppressor. These mutations can trigger the growth of tumors such as neurofibromas, benign tumors that develop on nerve cells.

The best way to see many of the features of the disease is to do FLAIR imaging (a type of ) on the brains of patients. In FLAIR images of neurofibromatosis 1 patients, there often are abnormally bright spots that likely indicate the presence of fluid between layers of myelin sheaths—the insulation surrounding certain —which may contribute to the cognitive deficits observed in patients.

Unidentified bright objects—the bright spots in the FLAIR images—have been traditionally defined and segmented (digitally separated for further study) manually, which requires intensive training and is time-consuming and expensive. The current work, led by first author and neuroscience Ph.D. student Emily Harriott and co-author and recent neuroscience Ph.D. graduate Tin Nguyen, tested and validated a semi-automated approach for detecting and segmenting UBOs in children and adolescents with neurofibromatosis 1. Cutting lab staff researcher Laura Barquero also participated in the study.

The new approach, which uses a tool called the Lesion Segmentation Tool, reliably identified and segmented UBOs and was much faster than doing the work manually. After establishing the utility of LST, the scientists explored possible correlations between total UBO volume and cognitive function. The researchers demonstrated that total UBO volume was related to single word reading ability, phonological awareness (recognizing and manipulating spoken parts of speech) and visuospatial skills, and participants with greater UBO volumes had lower scores on these cognitive measures.

Using automated tools will decrease the time and cost needed to analyze UBOs. Additionally, applying tools like LST to examine the relationships between UBO volumes and will help create and refine targeted pharmacological, academic and behavioral interventions that may improve neurofibromatosis 1 patients' quality of life.

More information: Emily M. Harriott et al, Using a semi-automated approach to quantify unidentified bright objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes, Magnetic Resonance Imaging (2023). DOI: 10.1016/j.mri.2022.12.022

Citation: Automated tool can link brain scans to cognitive deficits in people with neurofibromatosis type 1 (2023, March 15) retrieved 18 April 2024 from https://medicalxpress.com/news/2023-03-automated-tool-link-brain-scans.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Epilepsy drug stops nervous system tumor growth in mice

13 shares

Feedback to editors